Cargando…

Effects of the Introduction of Modern Immunotherapy on the Outcome of Isolated Limb Perfusion for Melanoma In-Transit Metastases

SIMPLE SUMMARY: Melanoma in-transit metastasis has long been effectively treated with isolated limb perfusion (ILP), a procedure where the limb is treated with high concentrations of heated chemotherapy. The recent treatment revolution with the introduction of modern systemic treatments has changed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holmberg, Carl-Jacob, Mattsson, Jan, Olofsson Bagge, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856283/ https://www.ncbi.nlm.nih.gov/pubmed/36672422 http://dx.doi.org/10.3390/cancers15020472

Ejemplares similares

The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion
por: Katsarelias, Dimitrios, et al.
Publicado: (2018)

Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant Melanoma
por: Belgrano, Valerio, et al.
Publicado: (2019)

Meta-Analysis of Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion as a Treatment for Uveal Melanoma Liver Metastases
por: Bethlehem, Martijn S., et al.
Publicado: (2021)

Leakage through the bone-marrow during isolated limb perfusion in the lower extremity
por: Katsarelias, Dimitrios, et al.
Publicado: (2019)

Surgery for gastrointestinal metastases of malignant melanoma — a retrospective exploratory study
por: Holmberg, Carl Jacob, et al.
Publicado: (2019)

Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients
por: Johansson, Junko, et al.
Publicado: (2018)

Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis
por: Johansson, Junko, et al.
Publicado: (2019)

Tumor Burden and Health-Related Quality of Life in Patients with Melanoma In-Transit Metastases
por: Wesslau, Hanna, et al.
Publicado: (2022)

Non-invasive and invasive measurement of skeletal muscular oxygenation during isolated limb perfusion
por: Corderfeldt Keiller, Anna, et al.
Publicado: (2022)

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)
por: Olofsson Bagge, Roger, et al.
Publicado: (2023)

Presence of tumor-infiltrating CD8(+) T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis
por: Johansson, Junko, et al.
Publicado: (2020)

20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters
por: Deroose, Jan P., et al.
Publicado: (2011)

Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
por: Olofsson Bagge, Roger, et al.
Publicado: (2015)

Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm)
por: Holmberg, Carl-Jacob, et al.
Publicado: (2023)

Role of Isolated Limb Perfusion in the Era of Targeted Therapies and Immunotherapy in Melanoma. A Systematic Review of The Literature
por: Sevilla-Ortega, Lourdes, et al.
Publicado: (2021)

MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma
por: Eldh, Maria, et al.
Publicado: (2014)

The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.
por: Scott, R. N., et al.
Publicado: (1992)

Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study
por: Helgadottir, Hildur, et al.
Publicado: (2023)

Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
por: Olofsson, Roger, et al.
Publicado: (2014)

Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion
por: Reintgen, Michael, et al.
Publicado: (2010)

Evaluation of intraoperative touch imprint cytology on axillary sentinel lymph nodes in invasive breast carcinomas, a retrospective study of 1227 patients comparing sensitivity in the different tumor subtypes
por: Pétursson, Hafsteinn Ingi, et al.
Publicado: (2018)

Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb.
por: Klaase, J. M., et al.
Publicado: (1994)

Occurrence and prognosis of lymph node metastases in patients selected for isolated limb perfusion with soft tissue sarcoma
por: Crettenand, François, et al.
Publicado: (2018)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

Introduction to modern electromagnetics
por: Durney, Carl H, et al.
Publicado: (1969)

Extensive necrosis of visceral melanoma metastases after immunotherapy
por: Stoeter, David, et al.
Publicado: (2008)

Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases
por: Ruschulte, Heiner, et al.
Publicado: (2013)

Indocyanine Green for Leakage Control in Isolated Limb Perfusion
por: Zucal, Isabel, et al.
Publicado: (2021)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy
por: Teterycz, Pawel, et al.
Publicado: (2020)

A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden
por: Isaksson, Karolin, et al.
Publicado: (2019)

Vascular Complications following Isolated Limb Perfusion for Local Recurrence of Extremity Melanoma: A Case Report and Literature Review
por: Trezzi, M., et al.
Publicado: (2011)

Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis
por: Ma, Qiufei, et al.
Publicado: (2016)

Immunotherapy as a Turning Point in the Treatment of Melanoma Brain Metastases
por: Fernandes, Gil Nuno Castro
Publicado: (2023)

Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy
por: Sah, Vasu R., et al.
Publicado: (2023)

Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions
por: Einarsdottir, Berglind O., et al.
Publicado: (2014)

Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases
por: Janeva, Slavica, et al.
Publicado: (2023)

Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2023)

The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study
por: Katsarelias, Dimitrios, et al.
Publicado: (2020)

Expression of Chemoresistance-Related Genes and Heat Shock Protein 72 in Hyperthermic Isolated Limb Perfusion of Malignant Melanoma: An Experimental Study
por: Knorr, C., et al.
Publicado: (2010)

The shaping of modern psychology. An historical introduction
por: Smith, Roger
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_56ghu0438i510jl2gidjvt9gtk